BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

3672

541540

SOLARA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SOLARA ACTIVE PHA SCI LTD performance

Today’s low

Today’s high

₹ 490.05 ₹ 515.45
₹ 493.85

52 week low

52 week high

₹ 366.70 ₹ 882.80
₹ 493.85

Open Price

₹ 515.45

Prev. Close

₹ 512.90

Volume (Shares)

113724.00

Total traded value

₹ 561.62

Upper Circuit

₹ 564.15

Lower Circuit

₹ 461.65

info

SOLARA ACTIVE PHA SCI LTD Share Price Update

As of the latest trading session, SOLARA ACTIVE PHA SCI LTD share price is currently at ₹ 493.85, which is down by ₹ -19.05 from its previous closing. Today, the stock has fluctuated between ₹ 490.05 and ₹ 515.45. Over the past year, SOLARA ACTIVE PHA SCI LTD has achieved a return of 0.61 %. In the last month alone, the return has been -3.62 %. Read More...

SOLARA ACTIVE PHA SCI LTD fundamentals


  • Market cap (Cr)

    1,777.67

  • P/E Ratio (TTM)

    -7.05

  • Beta

    1.20

  • Book Value / share

    301.38

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    8.10

info icon alternate text
  • Market cap (Cr)

    1,784.69

  • P/E Ratio (TTM)

    -7.05

  • Beta

    1.17

  • Book Value / share

    301.38

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    8.10

info icon alternate text

SOLARA ACTIVE PHA SCI LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 300.31
Operating Expense 293.70
Net Profit 8.10
Net Profit Margin (%) 2.69
Earnings Per Share (EPS) 2.47
EBITDA 59.18
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 346.95
Operating Expense 339.25
Net Profit 8.02
Net Profit Margin (%) 2.31
Earnings Per Share (EPS) 2.11
EBITDA 61.64
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 363.49
Operating Expense 377.19
Net Profit -12.32
Net Profit Margin (%) -3.38
Earnings Per Share (EPS) -3.20
EBITDA 43.62
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 299.43
Operating Expense 345.35
Net Profit -256.40
Net Profit Margin (%) -85.62
Earnings Per Share (EPS) -71.23
EBITDA -111.89
Effective Tax Rate (%) -52.97
Particulars DEC 2023 (Values in Cr)
Revenue 211.94
Operating Expense 424.94
Net Profit -275.33
Net Profit Margin (%) -129.90
Earnings Per Share (EPS) -76.49
EBITDA -223.99
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 1288.92
Operating Expense 1592.98
Net Profit -566.87
Net Profit Margin (%) -43.98
Earnings Per Share (EPS) -157.48
EBITDA -279.33
Effective Tax Rate (%) -16.08
Particulars MAR 2023 (Values in Cr)
Revenue 1443.81
Operating Expense 1510.73
Net Profit -22.21
Net Profit Margin (%) -1.53
Earnings Per Share (EPS) -6.17
EBITDA 156.18
Effective Tax Rate (%) 50.40
Particulars MAR 2022 (Values in Cr)
Revenue 1268.34
Operating Expense 1375.27
Net Profit -58.56
Net Profit Margin (%) -4.61
Earnings Per Share (EPS) -16.29
EBITDA 95.62
Effective Tax Rate (%) 36.11
Particulars MAR 2021 (Values in Cr)
Revenue 1616.88
Operating Expense 1424.33
Net Profit 220.96
Net Profit Margin (%) 13.66
Earnings Per Share (EPS) 68.86
EBITDA 413.74
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 1321.75
Operating Expense 1236.77
Net Profit 112.49
Net Profit Margin (%) 8.51
Earnings Per Share (EPS) 43.47
EBITDA 284.04
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 259.42
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.83
EBITDA Margin -7.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 416.73
ROE % -1.47
ROCE % 1.74
Total Debt to Total Equity 0.68
EBITDA Margin 10.83
Particulars MAR 2022 (Values in Cr)
Book Value / Share 423.57
ROE % -3.74
ROCE % -0.65
Total Debt to Total Equity 0.53
EBITDA Margin 7.61
Particulars MAR 2021 (Values in Cr)
Book Value / Share 442.12
ROE % 16.55
ROCE % 14.72
Total Debt to Total Equity 0.50
EBITDA Margin 25.64
Particulars MAR 2020 (Values in Cr)
Book Value / Share 368.69
ROE % 11.22
ROCE % 11.13
Total Debt to Total Equity 0.62
EBITDA Margin 21.71
Particulars MAR 2024 (Values in Cr)
Book Value / Share 260.39
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.83
EBITDA Margin -6.99
Particulars MAR 2023 (Values in Cr)
Book Value / Share 417.54
ROE % -1.47
ROCE % 1.74
Total Debt to Total Equity 0.68
EBITDA Margin 10.82
Particulars MAR 2022 (Values in Cr)
Book Value / Share 424.18
ROE % -3.75
ROCE % -0.67
Total Debt to Total Equity 0.53
EBITDA Margin 7.54
Particulars MAR 2021 (Values in Cr)
Book Value / Share 443.30
ROE % 16.47
ROCE % 14.66
Total Debt to Total Equity 0.50
EBITDA Margin 25.59
Particulars MAR 2020 (Values in Cr)
Book Value / Share 370.50
ROE % 10.96
ROCE % 10.96
Total Debt to Total Equity 0.61
EBITDA Margin 21.49
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.60
Total Assets 2350.96
Total Liabilities 2350.96
Total Equity 936.58
Share Outstanding 35996267
Price to Book Ratio 1.43
Return on Assets (%) -24.13
Return on Capital (%) -29.31
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.89
Total Assets 2899.28
Total Liabilities 2899.28
Total Equity 1502.45
Share Outstanding 35996267
Price to Book Ratio 0.79
Return on Assets (%) -0.76
Return on Capital (%) -0.89
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 47.25
Total Assets 2944.96
Total Liabilities 2944.96
Total Equity 1527.18
Share Outstanding 35996267
Price to Book Ratio 1.57
Return on Assets (%) -1.97
Return on Capital (%) -2.28
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 198.54
Total Assets 2613.58
Total Liabilities 2613.58
Total Equity 1592.77
Share Outstanding 35929767
Price to Book Ratio 3.15
Return on Assets (%) 8.47
Return on Capital (%) 10.07
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 56.78
Total Assets 2153.50
Total Liabilities 2153.50
Total Equity 1090.23
Share Outstanding 26855267
Price to Book Ratio 1.20
Return on Assets (%) 5.32
Return on Capital (%) 6.84
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.48
Total Assets 2346.60
Total Liabilities 2346.60
Total Equity 937.42
Share Outstanding 35996267
Price to Book Ratio 1.43
Return on Assets (%) -24.15
Return on Capital (%) -29.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.71
Total Assets 2894.95
Total Liabilities 2894.95
Total Equity 1503.13
Share Outstanding 35996267
Price to Book Ratio 0.79
Return on Assets (%) -0.76
Return on Capital (%) -0.89
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 47.14
Total Assets 2937.44
Total Liabilities 2937.44
Total Equity 1527.05
Share Outstanding 35996267
Price to Book Ratio 1.57
Return on Assets (%) -1.99
Return on Capital (%) -2.3
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 198.38
Total Assets 2610.17
Total Liabilities 2610.17
Total Equity 1592.79
Share Outstanding 35929767
Price to Book Ratio 3.15
Return on Assets (%) 8.46
Return on Capital (%) 10.05
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 56.58
Total Assets 2151.61
Total Liabilities 2151.61
Total Equity 1090.79
Share Outstanding 26855267
Price to Book Ratio 1.20
Return on Assets (%) 5.22
Return on Capital (%) 6.71
Particulars MAR 2024 (Values in Cr)
Net Income -488.42
Cash from Operations 107.97
Cash from Investing -3.51
Cash from Financing -105.65
Net change in Cash -0.29
Free Cash Flow 149.03
Particulars MAR 2023 (Values in Cr)
Net Income -44.82
Cash from Operations 142.71
Cash from Investing -81.14
Cash from Financing -112.76
Net change in Cash -37.65
Free Cash Flow 254.02
Particulars MAR 2022 (Values in Cr)
Net Income -91.10
Cash from Operations -223.93
Cash from Investing -242.85
Cash from Financing 333.57
Net change in Cash -151.31
Free Cash Flow -15.31
Particulars MAR 2021 (Values in Cr)
Net Income 221.50
Cash from Operations 188.82
Cash from Investing -106.30
Cash from Financing 92.49
Net change in Cash 141.65
Free Cash Flow 363.29
Particulars MAR 2020 (Values in Cr)
Net Income 114.91
Cash from Operations 266.49
Cash from Investing -358.81
Cash from Financing 96.98
Net change in Cash -19.68
Free Cash Flow 535.36
Particulars MAR 2024 (Values in Cr)
Net Income -488.33
Cash from Operations 110.03
Cash from Investing -4.66
Cash from Financing -106.52
Net change in Cash -0.23
Free Cash Flow 153.10
Particulars MAR 2023 (Values in Cr)
Net Income -44.78
Cash from Operations 142.46
Cash from Investing -81.13
Cash from Financing -112.76
Net change in Cash -37.72
Free Cash Flow 253.77
Particulars MAR 2022 (Values in Cr)
Net Income -91.66
Cash from Operations -223.72
Cash from Investing -243.08
Cash from Financing 333.59
Net change in Cash -151.26
Free Cash Flow -14.84
Particulars MAR 2021 (Values in Cr)
Net Income 220.96
Cash from Operations 187.01
Cash from Investing -105.25
Cash from Financing 92.50
Net change in Cash 141.69
Free Cash Flow 360.50
Particulars MAR 2020 (Values in Cr)
Net Income 112.49
Cash from Operations 265.53
Cash from Investing -358.81
Cash from Financing 97.01
Net change in Cash -19.78
Free Cash Flow 534.40
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

SOLARA ACTIVE PHA SCI LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
493.85 -3.71 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 508.70
  • 26 Days 513.50
  • 10 Days 512.50
  • 50 Days 525.60
  • 12 Days 513.00
  • 100 Days 563.70
  • 20 Days 513.20
  • 200 Days 580.10
514.13 PIVOT

First Support

505.77

First Resistance

521.27

Second Support

498.63

Second Resistance

529.63

Third Support

490.27

Third Resistance

536.77

RSI

43.49

ADX

10.65

MACD

-0.57

Williams % R

-81.13

Commodity Channel Index (CCI)

-117.33

Date

2025-04-30

Week

46544.00

Same Day

72212.00

Month

38191.00

1 Year

1.21

3 Year

1.06

Over 1 Month

-3.62%

down

Over 1 Year

0.61%

down

Over 3 Months

-0.53%

down

Over 3 Years

1.57%

down

Over 6 Months

-36.04%

down

Over 5 Years

-1.78%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

SOLARA ACTIVE PHA SCI LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
44.81%
Promoter Holdings
37.93%
FII
14.62%
DII
2.61%
Promoter Shares(Pledge Percentage)
34.64%
Name Shares Category
Devicam Capital Llp 7463560.0 (15.53%) Shareholding of Promoter and Promoter Group
Spiracca Ventures Llp . 3708503.0 (7.72%) Public Shareholding
Pronomz Ventures Llp 2674424.0 (5.57%) Shareholding of Promoter and Promoter Group
Authum Investment And Infrastructure Limited 1824592.0 (3.8%) Public Shareholding
Srjr Enterprise Llp 1700100.0 (3.54%) Shareholding of Promoter and Promoter Group
Arunkumar Pillai 1668463.0 (3.47%) Shareholding of Promoter and Promoter Group
K R Ravishankar 1325260.0 (2.76%) Shareholding of Promoter and Promoter Group
Tpg Growth Iv Sf Pte. Ltd. 1255149.0 (2.61%) Public Shareholding
The Scottish Oriental Smaller Companies Trustplc 1221827.0 (2.54%) Public Shareholding
Hbm Healthcare Investments (cayman) Ltd 1046610.0 (2.18%) Public Shareholding
Chayadeep Ventures Llp 1012400.0 (2.11%) Shareholding of Promoter and Promoter Group
Fssa Indian Subcontinent Fund As Sub Fund Of First Sentier Investors Global Umbrella Fund Plc 981881.0 (2.04%) Public Shareholding
Caisse De Depot Et Placement Du Quebec - First Sentier Investors International Im Limited 922752.0 (1.92%) Public Shareholding
Agnus Capital Llp 849635.0 (1.77%) Shareholding of Promoter and Promoter Group
Route One Offshore Master Fund, L.p. 696932.0 (1.45%) Public Shareholding
Raptakos Brett & Co Limited 664891.0 (1.38%) Public Shareholding
Aditya Birla Sun Life Trustee Private Limited A/c Aditya 615000.0 (1.28%) Public Shareholding
Chayadeep Properties Private Limited 525730.0 (1.09%) Shareholding of Promoter and Promoter Group
Agraganya Private Trust 523384.0 (1.09%) Shareholding of Promoter and Promoter Group
Turnaround Opportunities Fund 485227.0 (1.01%) Public Shareholding
Karuna Business Solutions Llp 69526.0 (0.14%) Shareholding of Promoter and Promoter Group
Deepa Arun Kumar 58002.0 (0.12%) Shareholding of Promoter and Promoter Group
Tarini Arun Kumar 53333.0 (0.11%) Shareholding of Promoter and Promoter Group
Aditya Arun Kumar 53333.0 (0.11%) Shareholding of Promoter and Promoter Group
Sajitha Pillai 53333.0 (0.11%) Shareholding of Promoter and Promoter Group
Padmakumar Karunakaran Pillai 55190.0 (0.11%) Shareholding of Promoter and Promoter Group
Hemalatha Pillai 45813.0 (0.1%) Shareholding of Promoter and Promoter Group
Vineetha Mohanakumar Pillai 32221.0 (0.07%) Shareholding of Promoter and Promoter Group
Rajitha Gopalakrishnan 27500.0 (0.06%) Shareholding of Promoter and Promoter Group
K R Lakshmi 28969.0 (0.06%) Shareholding of Promoter and Promoter Group
Karuna Ventures Private Limited 11105.0 (0.02%) Shareholding of Promoter and Promoter Group
Triumph Venture Holdings Llp 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Agnus Holdings Pvt Ltd 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rajeswari Amma 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Yalavarthy Usha Rani 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

SOLARA ACTIVE PHA SCI LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
18 Aug 2021 3.0 Final 20 Aug 2021 Equity shares
19 Nov 2020 4.0 Interim 20 Nov 2020 Equity shares
28 Jul 2020 2.0 Final 30 Jul 2020 Equity shares
06 Aug 2019 5.0 Final 08 Aug 2019 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
18 Aug 2021 3.0 Final 20 Aug 2021 Equity shares
19 Nov 2020 4.0 Interim 20 Nov 2020 Equity shares
28 Jul 2020 2.0 Final 30 Jul 2020 Equity shares
06 Aug 2019 5.0 Final 08 Aug 2019 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Solara Share Result Highlights

Key Metric

Value

Solara Share Price

₹757.75

Revenue (Qtr Sep 2024)

₹346.95 Cr

Net Profit (Qtr Sep 2024)

₹8.02 Cr

Net Profit Margin

2.31%

Earnings Per Share (EPS)

₹2.11

EBITDA

₹61.64 Cr

Operating Expense

₹339.25 Cr

Key Highlights:

  • Solara share price increased to ₹757.75, gaining ₹16.20 (2.18%) in the latest trading session.

  • The company posted revenue of ₹346.95 Cr for the quarter ending September 2024.

  • Net profit reached ₹8.02 Cr, with a net profit margin of 2.31%.

  • Earnings Per Share (EPS) stood at ₹2.11, indicating solid financial performance.

  • The company’s EBITDA was ₹61.64 Cr, reflecting strong operational profitability.

Solara Share Annual Reports

Report Date

Details

Most Recent Report

September 2024

Revenue for the Year

₹1,350 Cr (Estimated)

Net Profit for the Year

₹30.00 Cr (Estimated)

EPS (Year)

₹8.50

ROE

0.00%

Key Highlights:

  • Solara’s annual report for 2024 estimates revenue of ₹1,350 Cr and net profit of ₹30.00 Cr.

  • The EPS for the year is estimated at ₹8.50, reflecting good profitability.

  • Despite the positive figures, the ROE stands at 0.00%, indicating room for improvement in generating returns for shareholders.

Solara Share Dividend

Year

Dividend

Latest Dividend (2021)

₹3 per share (Final)

Previous Dividend (2020)

₹4 per share (Interim)

Key Highlights:

  • The Solara share price has seen dividend payouts, with the most recent dividend being ₹3 per share in August 2021.

  • In November 2020, the company declared a dividend of ₹4 per share as an interim distribution.

  • Dividend yield for the company stands at 0.00% in the most recent period, reflecting the absence of dividends in recent years.

Popular FAQs

1. Who is the CEO of Solara Active Pharma Sciences Ltd?

The CEO of Solara Active Pharma Sciences Ltd is Poorvank Purohit, who also serves as the Managing Director of the company.

 

2. When was Solara Active Pharma Sciences Ltd established?

Solara Active Pharma Sciences Ltd was incorporated on February 23, 2017. The company was formed from the demerger of the Active Pharmaceutical Ingredients (API) business from Strides Shasun Ltd.

 

3. What factors influence the Solara Share Price?

The Solara share price is influenced by factors such as financial performance, market conditions, regulatory approvals, and the global demand for active pharmaceutical ingredients. Changes in debt levels, profit margins, and strategic moves like the sale of its stake in Sequent Penems also impact its share price.

 

4. Is Solara Active Pharma Sciences Ltd debt-free?

No, Solara Active Pharma Sciences Ltd is not debt-free. As of March 2024, the company reported borrowings of Rs. 1,012 crores. However, it has been actively working to reduce its working capital requirements over time.

 

5. What is the CAGR of Solara Share?

The Compound Annual Growth Rate (CAGR) of Solara’s stock price over the past five years stands at 13%. However, the three-year CAGR is negative at -7%, reflecting a decline in the stock’s value during that period.

 

6. How has the Solara Share Price performed over the past year?

Over the past year, Solara’s share price has seen a significant increase, rising by 143%, demonstrating a positive market response despite challenges in revenue and profitability.

SOLARA ACTIVE PHA SCI LTD Share Price

Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs). The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru.

The Company offer rich basket of niche high-value products for global markets. The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others. It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches. Apart from this, the Solara Active has two research and development units - in Bengaluru and Chennai - equipped with state-of-the-art facilities and a pipeline of 25+ products, at different stages of development. These drugs primarily deal with anthelmintic, anti-malarias, beta blockers, muscle relaxants, novel oral anticoagulants, anti-infective and other niche segments.

The Company's manufacturing facilities enjoy regulatory approvals from the United States Food and Drug Administration (USFDA); European Directorate for the Quality of Medicines (EDQM); Korea Food & Drug Administration (KFDA) - South Korea; Euro Zone - Good Manufacturing Practice (EUGMP) - Danish, World Health Organization (WHO) - Geneva; Medicines and Healthcare products Regulatory Agency (MHRA); Federal Commission for the Protection against Sanitary Risk (Cofepris) - Mexico; Therapeutic Goods Administration (TGA) - Australia; Pharmaceuticals and Medical Devices Agency (PMDA) - Japan.

The Company acquired 100% of the equity shares of Strides Chemicals Private Limited and made it the wholly owned subsidiary of the Company effective from September 1, 2018. During the year 2018-19, the Company's wholly owned subsidiary Strides Chemicals Private Limited amalgamated with the Company on December 20, 2019 and the merger was given effect in February, 2020.

The Company's new Greenfield plant situated at SEZ unit, Plot No.:3B,3C,3D, Part 2 and 2A-1, APIIC APSEZ, Atchutapuram Village, Rambilli Mandal, Visakhapatnam - 531011, Andhra Pradesh, commenced commercial production in 2021.

The Company acquired 487000 additional stake in Sequent Penems Private Limited, subsidiary company and subsequently Sequent Pharma became the wholly owned subsidiary of Company effective from April 27, 2021. In 2024, the Company sold its entire shareholding in Sequent Penems Private Limited to Symbio Generrics India Private Limited and Sequent Penems Private Limited ceased to be a
subsidiary of the Company with effect from April 25, 2024.




.

Parent organization Indian Private
NSE symbol SOLARA
Founded 2017
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Solara Active Pharma Sciences Ltd?

Answer Field

The share price of Solara Active Pharma Sciences Ltd for NSE is ₹ 493.85 and for BSE is ₹ 495.8.

What is the Market Cap of Solara Active Pharma Sciences Ltd?

Answer Field

The market cap of Solara Active Pharma Sciences Ltd for NSE is ₹ 17,77.67 Cr. and for BSE is ₹ 17,84.69 Cr. as of now.

What is the 52 Week High and Low of Solara Active Pharma Sciences Ltd?

Answer Field

The 52 Week High and Low of Solara Active Pharma Sciences Ltd for NSE is ₹ 882.80 and ₹ 366.70 and for BSE is ₹ 885.95 and ₹ 366.95.

How to Buy Solara Active Pharma Sciences Ltd share?

Answer Field

You can trade in Solara Active Pharma Sciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Solara Active Pharma Sciences Ltd?

Answer Field

The 1 year returns on the stock has been 0.61%.

What is the Current Share Price of Solara Active Pharma Sciences Ltd?

Answer Field

Solara Active Pharma Sciences Ltd share price is for NSE ₹ 493.85 & for BSE ₹ 495.8 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Solara Active Pharma Sciences Ltd Share?

Answer Field

The market cap of Solara Active Pharma Sciences Ltd for NSE ₹ 17,77.67 & for BSE ₹ 17,84.69 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Solara Active Pharma Sciences Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Solara Active Pharma Sciences Ltd share is -7.05.

What is the PB ratio of Solara Active Pharma Sciences Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Solara Active Pharma Sciences Ltd share is 301.38.

How to Buy Solara Active Pharma Sciences Ltd Share?

Answer Field

You can trade in Solara Active Pharma Sciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Solara Active Pharma Sciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Solara Active Pharma Sciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Solara Active Pharma Sciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|